Publications 2020

Taghavi, Katayoun; Moono, Misinzo; Mwanahamuntu, Mulindi; Basu, Partha; Limacher, Andreas et al. (2020). Screening test accuracy to improve detection of precancerous lesions of the cervix in women living with HIV: a study protocol. BMJ Open, 10 (12), S. e037955.
Petoumenos, Kathy; Kuwanda, Locadiah; Ryom, Lene; Mocroft, Amanda; Reiss, Peter et al. (2020). Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study. Journal of Acquired Immune Deficiency Syndromes (1999), Publish Ahead of Print.
Desmonde, Sophie; Ciaranello, Andrea L.; Malateste, Karen; Musick, Beverly; Patten, Gabriela et al. (2020). Age-specific mortality rate ratios in adolescents and youth aged 10–24 years living with perinatally versus non-perinatally-acquired HIV. AIDS, Publish Ahead of Print.
Han, Win Min; Bijker, Rimke; Chandrasekaran, Ezhilarasi; Pujari, Sanjay; Ng, Oon Tek et al. (2020). Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific. Journal of Acquired Immune Deficiency Syndromes (1999), 85 (4), S. 489–497.
Giganti, Mark J. & Shepherd, Bryan E. (2020). Multiple-Imputation Variance Estimation in Studies With Missing or Misclassified Inclusion Criteria. American Journal of Epidemiology, 189 (12), S. 1628–1632.
Tsondai, Priscilla R.; Braithwaite, Kate; Fatti, Geoffrey; Bolton Moore, Carolyn; Chimbetete, Cleophas et al. (2020). Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa. AIDS (London, England), 34 (15), S. 2275–2284.
Bernard, Charlotte; Font, Hélène; Diallo, Zélica; Ahonon, Richard; Tine, Judicaël Malick et al. (2020). Prevalence and factors associated with severe depressive symptoms in older west African people living with HIV. BMC Psychiatry, 20 (1), S. 442–442.
Marbaniang, Ivan; Sangle, Shashikala; Nimkar, Smita; Zarekar, Kanta; Salvi, Sonali et al. (2020). The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India. BMC Public Health, 20 (1).
Taghavi, Katayoun; Rohner, Eliane; Basu, Partha; Low, Nicola; Rutjes, Anne et al. (2020). Screening test accuracy of portable devices that can be used to perform colposcopy for detecting CIN2+ in low- and middle-income countries: a systematic review and meta-analysis. BMC Women’s Health, 20 (1).
Hauser, Anthony; Kusejko, Katharina; Johnson, Leigh F.; Günthard, Huldrych F.; Riou, Julien et al. (2020). Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study. PLOS Medicine, 17 (12), S. e1003397–e1003397.
Penn-Nicholson, Adam; Mbandi, Stanley Kimbung; Thompson, Ethan; Mendelsohn, Simon C.; Suliman, Sara et al. (2020). RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Scientific Reports, 10 (1).
Oliveira-de-Souza, Deivide; Vinhaes, Caian L.; Arriaga, María B.; Kumar, Nathella Pavan; Queiroz, Artur T. L. et al. (2020). Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis. Scientific Reports, 10 (1).
Haas, Andreas D.; Technau, Karl‐Günter; Pahad, Shenaaz; Braithwaite, Kate; Madzivhandila, Mampho et al. (2020). Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa. Journal of the International AIDS Society, 23 (12).
Anderegg, Nanina; Hector, Jonas; Jefferys, Laura F.; Burgos-Soto, Juan; Hobbins, Michael A. et al. (2020). Loss to follow-up correction increased mortality estimates in HIV–positive people on antiretroviral therapy in Mozambique. Journal of Clinical Epidemiology, 128, S. 83–92.
Kim, H. Nina (2020). Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy. Current Hepatology Reports, 19 (4), S. 345–353.
Han, W. M.; Jiamsakul, A.; Jantarapakde, J.; Yunihastuti, E.; Choi, J. Y. et al. (2020). Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV. HIV Medicine.
Mpofu, Philani B.; Bakoyannis, Giorgos; Yiannoutsos, Constantin T.; Mwangi, Ann W. & Mburu, Margaret (2020). A pseudo‐likelihood method for estimating misclassification probabilities in competing‐risks settings when true‐event data are partially observed. Biometrical Journal, 62 (7), S. 1747–1768.
Tao, Ran; Lotspeich, Sarah C.; Amorim, Gustavo; Shaw, Pamela A. & Shepherd, Bryan E. (2020). Efficient semiparametric inference for two-phase studies with outcome and covariate measurement errors. Statistics in Medicine, S. sim.8799-sim.8799.
Ross, J.; Jiamsakul, A.; Kumarasamy, N.; Azwa, I.; Merati, T. P. et al. (2020). Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific. HIV Medicine, S. hiv.13006-hiv.13006.
Desmonde, Sophie; Neilan, Anne M.; Musick, Beverly; Patten, Gabriela; Chokephaibulkit, Kulkanya et al. (2020). Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Gl. Journal of the International AIDS Society, 23 (10), S. e25617–e25617.
Reichmuth, Martina L.; Hömke, Rico; Zürcher, Kathrin; Sander, Peter; Avihingsanon, Anchalee et al. (2020). Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrobial Agents and Chemotherapy, 64 (11).
Arikawa, Shino; Dumazert, Patricia; Messou, Eugène; Burgos-Soto, Juan; Tiendrebeogo, Thierry et al. (2020). Childbearing desire and reproductive behaviors among women living with HIV: A cross-sectional study in Abidjan, Côte d’Ivoire. PLoS ONE, 15 (10 October).
Patsis, Ioannis; Goodrich, Suzanne; Yiannoutsos, Constantin T.; Brown, Steven A.; Musick, Beverly S. et al. (2020). Lower rates of ART initiation and decreased retention among ART-naïve patients who consume alcohol enrolling in HIV care and treatment programs in Kenya and Uganda. PLoS ONE, 15 (10 October 2020).
Haas, Andreas D.; Ruffieux, Yann; van den Heuvel, Leigh Luella; Lund, Crick; Boulle, Andrew et al. (2020). Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records. The Lancet Global Health, 8 (10), S. e1326–e1334.
Rebeiro, Peter F.; Duda, Stephany N.; Wools-Kaloustian, Kara K.; Nash, Denis & Althoff, Keri N. (2020). Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses. Journal of the International AIDS Society, 23 (10), S. e25627–e25627.
Demitto, Fernanda O.; Araújo-Pereira, Mariana; Schmaltz, Carolina A.; Sant’Anna, Flávia M.; Arriaga, María B. et al. (2020). Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV. Frontiers in Immunology, 11.
Seth, Divya; Williams, Victoria L.; McMahon, Devon E.; Regan, Susan; Busakhala, Naftali et al. (2020). The role of dermatology in Kaposi sarcoma diagnosis across three regions in sub-Saharan Africa. Journal of the American Academy of Dermatology.
Parcesepe, Angela M.; Lancaster, Kathryn; Edelman, E. Jennifer; DeBoni, Raquel; Ross, Jeremy et al. (2020). Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS ONE, 15 (8 August), S. e0237772–e0237772.
Boulle, Andrew; Davies, Mary-Ann; Hussey, Hannah; Ismail, Muzzammil; Morden, Erna et al. (2020). Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clinical Infectious Diseases.
Marbaniang, Ivan; Sangle, Shashikala; Nimkar, Smita; Zarekar, Kanta; Salvi, Sonali et al. (2020). The Burden of Anxiety During the COVID-19 Pandemic Among People Living with HIV (PLHIV) in Pune, India. Research Square.
Zürcher, Kathrin; Morrow, Carl; Riou, Julien; Ballif, Marie; Koch, Anastasia Sideris et al. (2020). Novel approach to estimate tuberculosis transmission in primary care clinics in sub-Saharan Africa: protocol of a prospective study. BMJ Open, 10 (8), S. e036214–e036214.
Sohn, Annette H.; Lumbiganon, Pagakrong; Kurniati, Nia; Lapphra, Keswadee; Law, Matthew et al. (2020). Determining standardized causes of death of infants, children, and adolescents living with HIV in Asia. AIDS (London, England), 34 (10), S. 1527–1537.
Yunihastuti, Evy; Teeratakulpisarn, Nipat; Jeo, Wifanto Saditya; Nilasari, Hanny; Rachmadi, Lisnawati et al. (2020). Incidence, clearance, persistence and factors related with high-risk anal HPV persistence in South-East Asian MSM and transgender women. AIDS (London, England).
Loiseau, Chloé; Brites, Daniela; Reinhard, Miriam; Zürcher, Kathrin; Borrell, Sonia et al. (2020). HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy.
Duda, Stephany N.; Musick, Beverly S.; Davies, Mary-Ann; Sohn, Annette H.; Ledergerber, Bruno et al. (2020). The IeDEA Data Exchange Standard: a common data model for global HIV cohort collaboration (preprint). Health Informatics.
Tchounga, Boris; Horo, Apollinaire; Boni, Simon; Tanon, Aristophane; Folquet, Madeleine Amorissani et al. (2020). Human papilloma viruses infection among adolescent females perinatally infected with HIV in Côte d’Ivoire. Sexually Transmitted Infections, S. sextrans-2019-054420.
Adedimeji, Adebola; Ajeh, Rogers; Dzudie, Anastase; Kendowo, Ernestine; Fuhngwa, Norbert et al. (2020). Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon. Journal of Clinical Virology, 128.
Chan, Andrew T.; Drew, David A.; Nguyen, Long H.; Joshi, Amit D.; Ma, Wenjie et al. (2020). The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 29 (7), S. 1283–1289.
Patten, Gabriela; Puthanakit, Thanyawee; McGowan, Catherine C.; Wools-Kaloustian, Kara; Hazra, Rohan et al. (2020). Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium. Journal of the International AIDS Society, 23 (7).
Zaniewski, Elizabeth; Dao Ostinelli, Cam H.; Chammartin, Frédérique; Maxwell, Nicola; Davies, Mary-Ann et al. (2020). Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa. Journal of the International AIDS Society, 23 (7), S. e25546–e25546.
Sudjaritruk, Tavitiya; Teeraananchai, Sirinya; Kariminia, Azar; Lapphra, Keswadee; Kumarasamy, Nagalingeswaran et al. (2020). Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study. Journal of the International AIDS Society, 23 (7).
Tchakounte Youngui, Boris; Coffie, Patrick; Messou, Eugène; Poda, Armel; Fortes Deguenonvo, Louise et al. (2020). Incidence of Tuberculosis During the First Year of Antiretroviral Treatment in West African HIV-Infected Adults. Open Forum Infectious Diseases, 7 (6).
Bartlett, Adam W.; Sudjaritruk, Tavitiya; Mohamed, Thahira J.; Anugulruengkitt, Suvaporn; Kumarasamy, Nagalingeswaran et al. (2020). Identification, management and outcomes of combination antiretroviral treatment failure in adolescents with perinatal HIV infection in Asia. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America.
Boettiger, David C.; Newall, Anthony T.; Chattranukulchai, Pairoj; Chaiwarith, Romanee; Khusuwan, Suwimon et al. (2020). Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis. Journal of the International AIDS Society, 23 Suppl 1 (S1), S. e25494–e25494.
Osler, Meg; Cornell, Morna; Ford, Nathan; Hilderbrand, Katherine; Goemaere, Eric et al. (2020). Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis. Journal of the International AIDS Society, 23 Suppl 2 (S2), S. e25530–e25530.
Makusha, Tawanda; van Rooyen, Heidi & Cornell, Morna (2020). Reframing the approach to heterosexual men in the HIV epidemic in sub-Saharan Africa. Journal of the International AIDS Society, 23 Suppl 2 (S2), S. e25510–e25510.
Dovel, Kathryn; Dworkin, Shari L.; Cornell, Morna; Coates, Thomas J. & Yeatman, Sara (2020). Gendered health institutions: examining the organization of health services and men’s use of HIV testing in Malawi. Journal of the International AIDS Society, 23 (S2).
Ross, Jonathan; Ribakare, Muhayimpundu; Remera, Eric; Murenzi, Gad; Munyaneza, Athanase et al. (2020). High levels of viral load monitoring and viral suppression under Treat All in Rwanda – a cross‐sectional study. Journal of the International AIDS Society, 23 (6).
Rebeiro, Peter F.; Cohen, Mollie J.; Ewing, Heather M.; Figueiredo, Marina Cruvinel; Peetluk, Lauren Saag et al. (2020). Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies. BMC Public Health, 20 (1), S. 897–897.
Johnson, Leigh F.; Mutemaringa, Themba; Mutemaringa, Themba; Heekes, Alexa; Heekes, Alexa et al. (2020). Effect of HIV Infection and Antiretroviral Treatment on Pregnancy Rates in the Western Cape Province of South Africa. Journal of Infectious Diseases, 221 (12), S. 1953–1962.

Adherence 2018 announcement

Adherence 2018 (13th International Conference on HIV Treatment and Prevention Adherence) will take place June 8-10, 2018, at the Loews Miami Beach Hotel in Miami, FL, USA. Sponsored by the International Association of Providers of AIDS Care (IAPAC), this annual series of conferences features the presentation and discussion of HIV treatment and biomedical prevention adherence research, as well as current behavioral and clinical perspectives in practicum, within the context of achieving an optimized continuum of HIV care and prevention. Continue reading “Adherence 2018 announcement”

CROI 2018 announcement

CROI 2018 will be held from March 4 to 7, 2018, in Boston, Massachusetts, at the Hynes Convention Center. Please note that CROI 2018 will be held from Sunday to Wednesday.

CROI has simplified and expanded the registration process, especially for abstract submitters (regardless of if the work was accepted).  They are increasing the limit on number of authors from 10 to 15, and allowing authors on non-accepted abstracts to register before we open for general registration. They are particularly interested in encouraging new investigators to submit to and attend CROI.

Abstract deadline is Sep 27, per slide.

Important Dates and Details

  •  September 27: General Abstract Submission Closes
  •  January 16: Late Breaking Abstract Submission Closes
  •  New Next year: easier and earlier access to registration for   Abstract Submitters and their collaborators

More details at:

*CROI begins on a Sunday next year

16th International Conference on Malignancies in HIV/AIDS

The NCI invites to join us at the 16th International Conference on Malignancies in HIV/AIDS (ICMH) previously named the International Conference on Malignancies  in AIDS and Other Acquired Immunodeficiencies (ICMAOI). The meeting will take place October 23-24, 2017, at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland.

This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.

Recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical investigation of malignant diseases associated with HIV and other acquired immunodeficiency states will be shared at this conference. Our objective is to facilitate the exchange of information between laboratory and clinical researchers so as to accelerate the translation of basic scientific discoveries into clinical applications.

Registration and further information on


Prevent HIV, test and treat all – WHO support for country impact Progress report 2016

World AIDS Day is 1st December each year, an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV and to commemorate people who have died.

This year, during the same week the WHO launched their 2016 global HIV progress report alongside their updated guidelines on HIV self-testing and partner notification.

Several IeDEA-WHO collaboration analyses from both the 2015 and 2016 rounds of this collaboration were cited in chapter three (Country action and WHO support) of this latest WHO progress report (see pages 28-30 & 38). Many thanks to the IeDEA teams for your continued commitment and support of this evolving and expanding collaboration with WHO.

IeDEA at AIDS 2016 – Durban, South Africa

IeDEA investigators had multiple abstract presentations and other invited talks throughout the pre-conference and main conference programs in July.

We were also invited to join the ALPHA network, the MeSH Consortium, and the HIV Modelling Consortium who hosted a booth in the Exhibition Hall where conference participants could learn more about how these collaborations are utilizing data to guide the global HIV response.


Read the slides “IeDEA at IAS 2016 – Durban, South Africa”

JIAS Call for Papers: Misdiagnosis of HIV Infection

Misdiagnosis of HIV infection has important implications for individuals and for public health. With the exponential expansion of HIV testing using multiple technologies, the potential for both false positive and false negative results has similarly grown.

HIV testing technologies range from rapid diagnostic tests and other technologies that enable testing at the point-of-care or near point-of care, to those that are used exclusively in high-level facilities and laboratories. Although most technologies for HIV testing have high sensitivity and specificity and are highly accurate when used in a validated national algorithm, the volume of tests conducted (over 150 million tests in 2014 alone), could result in thousands of misdiagnosed cases, particularly if not conducted correctly.

Continue reading “JIAS Call for Papers: Misdiagnosis of HIV Infection”